---

---

symbols : NVAX    exchanges : Nyse   

save search

---

Global Vaccines Market Research Report 2022-2027: A $200+ Billion Industry - Forecasts, Company Market Share and Expert Market Estimates for Vaccine Categories
Published: 2023-02-08 (Crawled : 16:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M |

Health Technology

| -39.73% | O: -0.09% H: 1.26% C: 0.99%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -9.34% | O: -0.06% H: 0.77% C: 0.19%
EBS | News | $2.18 -4.8% 0.0% 800K |

Health Technology

| -84.54% | O: -0.78% H: 0.79% C: -5.29%
SNGX | $0.385 -3.75% -3.9% 490K |

Health Technology

| -94.37% | O: -0.07% H: 4.9% C: 2.27%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 2.5% | O: 3.05% H: 0.0% C: 0.0%
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| -61.89% | O: 0.0% H: 1.74% C: -4.13%
INO | $10.1 -2.6% -2.67% 250K |

Health Technology

| 446.24% | O: -1.61% H: 2.73% C: -8.47%
BNTX | News | $88.18 -0.35% -0.35% 280K |

Health Technology

| -38.01% | O: -1.35% H: 1.53% C: 0.68%
research global report vaccine market

---

Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants
Published: 2022-10-12 (Crawled : 13:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -7.72% | O: 1.29% H: 0.0% C: 0.0%
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| -78.12% | O: 1.27% H: 5.93% C: 5.36%
covid-19 vaccine prototype

---

Top MNCs lauded by Frost and Sullivan Institute for their Commitment to ESG with Enlightened Growth Leadership Awards 2022
Published: 2022-09-30 (Crawled : 15:20) - prnewswire.com
MODV 4 | $24.78 10.04% 9.12% 280K |

Health Care and Social Assistan...

| -75.53% | O: -0.69% H: 3.21% C: -1.11%
RYAM 4 | $4.12 1.48% 0.0% 340K |

Process Industries

| 24.47% | O: -1.21% H: 3.67% C: -3.67%
PINS 4 | $32.85 -0.52% -4.29% 8.3M |

Technology Services

| 41.66% | O: -0.82% H: 3.74% C: 1.3%
PAYC 4 | $187.91 -0.1% 0.0% 540K |

Technology Services

| -43.81% | O: -0.21% H: 2.15% C: -1.12%
PARR | $32.69 -0.18% 0.0% 650K |

Energy Minerals

| 105.73% | O: -1.51% H: 6.39% C: 4.86%
OVV | $52.9 0.25% -0.64% 2.1M |

Energy Minerals

| 16.21% | O: -1.43% H: 3.87% C: 2.52%
OGE | $34.32 1.18% 0.0% 2.2M |

Utilities

| -8.28% | O: 0.59% H: 0.32% C: -3.13%
NTR | $52.29 0.04% 0.0% 1.1M |

Process Industries

| -37.44% | O: -0.67% H: 2.38% C: 0.43%
NRG | $72.61 1.57% 0.54% 2.8M |

Utilities

| 85.32% | O: 0.51% H: 0.46% C: -2.82%
NEM | News | $38.6 2.36% -0.26% 11M |

Non-Energy Minerals

| -7.57% | O: 0.05% H: 2.27% C: 0.6%
MLI 4 | $57.96 0.91% 0.0% 1.6M |

Producer Manufacturing

| -2.37% | O: 0.15% H: 2.69% C: -0.03%
MSCI | $464.65 4.18% 0.8% 2.2M |

Technology Services

| 9.79% | O: -0.26% H: 2.13% C: -0.08%
REGN | News | $906.55 -0.09% -0.08% 370K |

Health Technology

| 31.04% | O: 0.37% H: 1.15% C: -0.8%
QCOM | $163.63 1.41% 1.39% 6.1M |

Electronic Technology

| 42.49% | O: -0.94% H: 2.22% C: -0.69%
PYPL 4 | $64.84 0.64% 0.63% 7.8M |

Technology Services

| -26.9% | O: -0.85% H: 1.79% C: -2.14%
OMCL | News | $27.45 -3.45% -3.57% 440K |

Technology Services

| -68.77% | O: 0.17% H: 3.06% C: -1.09%
ZEUS | $67.73 -1.74% -1.77% 44K |

Non-Energy Minerals

| 193.48% | O: -0.65% H: 2.1% C: -0.26%
NTNX | $60.88 -0.31% -0.31% 970K |

Technology Services

| 188.3% | O: -0.47% H: 2.95% C: -0.9%
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| -77.65% | O: -0.38% H: 5.95% C: -1.62%
NBIX | News 4 | $138.91 -0.84% -0.85% 880K |

Health Technology

| 35.24% | O: 0.27% H: 3.81% C: 3.08%
NFLX | $554.75 -3.98% -4.15% 5.3M |

Consumer Services

| 131.58% | O: -1.13% H: 2.3% C: -0.66%
MRNA | News S | $108.82 0.86% 0.85% 3.4M |

Health Technology

| -7.81% | O: 0.31% H: 3.5% C: -0.16%
MKSI | $113.72 1.03% 1.02% 610K |

Electronic Technology

| 33.8% | O: -1.59% H: 1.55% C: -1.25%
awards esg growth

---

Novavax Reports First Quarter 2022 Financial Results and Operational Highlights
Published: 2022-05-09 (Crawled : 22:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -9.32% | O: -0.69% H: 0.28% C: -1.1%
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| -92.76% | O: 0.09% H: 5.27% C: -7.13%
results

---

BioSpace Movers & Shakers, April 1
Published: 2022-04-01 (Crawled : 15:00) - biospace.com/
RCOR | $3.2 0.0% |

| -24.53% | O: 0.0% H: 3.19% C: -4.01%
WMT | News | $59.87 1.32% -0.23% 19M |

Retail Trade

| -59.8% | O: 0.5% H: 1.08% C: 0.9%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 12.08% | O: -0.64% H: 0.6% C: 0.57%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -17.49% | O: -1.39% H: 0.0% C: 0.0%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -33.1% | O: 0.22% H: 1.01% C: 0.86%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -9.69% | O: 0.41% H: 0.11% C: -0.22%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -8.27% | O: -0.31% H: 0.0% C: 0.0%
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| -94.37% | O: -0.48% H: 4.07% C: 1.39%
NKTX | $7.16 -5.29% -5.59% 680K |

Health Technology

| -36.99% | O: -1.23% H: 4.98% C: 1.78%
ALEC | $5.27 -1.31% -1.33% 380K |

Health Technology

| -63.16% | O: -0.21% H: 2.39% C: -1.05%

---

New Variants Throw the Spotlight on Booster Shots of COVID-19 Vaccines - According to New Research from StrategyR
Published: 2022-03-10 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -5.34% | O: 2.52% H: 1.67% C: 1.67%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -12.84% | O: -0.85% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -7.01% | O: -0.12% H: 0.0% C: 0.0%
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| -94.75% | O: -1.99% H: 2.84% C: 0.35%
MRNA | News S | $108.82 0.86% 0.85% 3.4M |

Health Technology

| -23.61% | O: -2.09% H: 0.95% C: 0.01%
covid-19 research covid vaccine

---

Global COVID-19 Vaccines Market Report 2022: Leading Vaccine Companies Stress on Booster Dose
Published: 2022-02-02 (Crawled : 21:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -12.88% | O: 1.26% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -8.97% | O: -0.06% H: 0.0% C: 0.0%
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| -95.55% | O: -4.8% H: 4.69% C: -0.33%
MRNA | News S | $108.82 0.86% 0.85% 3.4M |

Health Technology

| -36.47% | O: -3.66% H: 3.05% C: -0.68%
covid-19 covid report vaccine

---

As Omicron Strain Fuels Fresh Waves of Infections Across the Globe, Mutating Coronavirus is the New Pandemic Challenge in 2022
Published: 2022-01-04 (Crawled : 17:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -12.94% | O: 0.51% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -6.38% | O: -2.03% H: 0.0% C: 0.0%
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| -97.1% | O: -2.03% H: 1.27% C: -1.11%
MRNA | News S | $108.82 0.86% 0.85% 3.4M |

Health Technology

| -53.69% | O: -1.15% H: 0.0% C: 0.0%
infection infections

---

Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine
Published: 2021-12-16 (Crawled : 05:00) - prnewswire.com
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -2.29% | O: 1.18% H: 0.0% C: 0.0%
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| -97.55% | O: 5.55% H: 0.0% C: 0.0%
covid-19 new drug application drug approval covid vaccine submission

---

ALERT: Novavax, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - NVAX
Published: 2021-11-16 (Crawled : 02:00) - prnewswire.com
SNAP | News S | $11.08 -2.72% -4.25% 31M |

Technology Services

| -79.53% | O: 2.63% H: 0.0% C: 0.0%
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| -97.59% | O: -2.38% H: 0.0% C: 0.0%

---

Novavax Reports Third Quarter 2021 Financial Results and Operational Highlights
Published: 2021-11-04 (Crawled : 23:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -7.09% | O: 0.35% H: 0.91% C: 0.77%
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| -97.87% | O: -5.97% H: 2.42% C: -2.26%
financial results results

---

Worldwide Vaccine Industry to 2027 - Key Drivers, Restraints and Opportunities
Published: 2021-10-13 (Crawled : 19:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -44.68% | O: 1.46% H: 0.0% C: -0.4%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -6.95% | O: 0.32% H: 0.9% C: 0.25%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 5.31% | O: 0.28% H: 0.06% C: -0.49%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -1.61% | O: 1.2% H: 0.08% C: -0.43%
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| -97.51% | O: 2.18% H: 2.72% C: -0.16%
vaccine

---

Novavax Announces Leadership Appointment and Updates
Published: 2021-10-04 (Crawled : 20:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -6.96% | O: 0.4% H: 0.78% C: -0.18%
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| -97.67% | O: 1.81% H: 2.04% C: -6.34%

---

Novavax to Participate in Upcoming September Conferences
Published: 2021-09-09 (Crawled : 18:00) - biospace.com/
MS | News 0 d | $93.85 0.1% 0.0% 4.8M |

Finance

| -9.38% | O: -0.21% H: 1.82% C: 0.47%
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| -98.44% | O: 0.45% H: 2.28% C: -3.44%
conference

---

Approximately 53% of Global Population to be Fully Vaccinated by the End of 2021
Published: 2021-09-02 (Crawled : 16:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -14.73% | O: 0.35% H: 0.49% C: 0.34%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -9.68% | O: 0.13% H: 0.28% C: 0.0%
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| -98.35% | O: 0.15% H: 3.58% C: 2.59%
MRNA | News S | $108.82 0.86% 0.85% 3.4M |

Health Technology

| -72.09% | O: 0.82% H: 2.46% C: 1.15%
vaccine

---

BioSpace Movers & Shakers, July 2
Published: 2021-07-02 (Crawled : 12:00) - biospace.com/
PEN 4 | $206.15 0.22% 0.0% 340K |

Health Technology

| -25.39% | O: 0.34% H: 0.0% C: -1.34%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -10.74% | O: 0.04% H: 1.98% C: 1.78%
BAX | $40.93 -0.22% 0.0% 2.2M |

Health Technology

| -49.76% | O: 0.0% H: 0.43% C: 0.36%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -9.73% | O: -0.91% H: 0.0% C: 0.0%
RLMD | $3.85 -1.54% -1.56% 110K |

Health Technology

| -88.5% | O: -0.27% H: 0.0% C: -2.6%
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| -98.08% | O: -0.49% H: 0.0% C: 0.0%
LEGN | News | $45.205 -4.73% -4.97% 1.1M |

Health Technology

| 8.11% | O: -2.73% H: 1.85% C: 0.91%
BIIB | $201.91 4.52% 4.32% 3.3M |

Health Technology

| -42.11% | O: 0.18% H: 0.15% C: -0.23%
space spac

---

North America Preventive Vaccines Market: COVID-19 Impact and Growth Opportunity 2021-2026
Published: 2021-06-11 (Crawled : 20:00) - prnewswire.com
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| Email alert Add to watchlist
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| Email alert Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| Email alert Add to watchlist
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| Email alert Add to watchlist
covid vaccine growth covid-19

---

European Vaccines Market 2020-2026 by Type, Disease, Administration, Patient, and Country
Published: 2021-06-10 (Crawled : 19:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -11.34% | O: -0.01% H: 0.01% C: -1.26%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 1.57% | O: 0.05% H: 0.12% C: -0.25%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -11.78% | O: 0.13% H: 0.11% C: -0.09%
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| -97.98% | O: -0.21% H: 3.31% C: 2.53%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 21.01% | O: 0.49% H: 0.03% C: -0.61%
disease europe vaccine

---

Global Preventive Vaccines Market by Type, Disease, Administration, Patient, and Region 2020-2026
Published: 2021-06-09 (Crawled : 22:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -10.54% | O: 0.25% H: 0.95% C: 0.65%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 3.31% | O: 0.76% H: 0.98% C: 0.95%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -10.11% | O: 1.21% H: 1.07% C: 0.67%
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| -98.02% | O: -1.89% H: 3.4% C: -0.36%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 23.61% | O: 0.94% H: 1.27% C: 1.2%
disease vaccine

---

Global Coronavirus (COVID-19) Vaccines Markets, 2019-2020 & 2027: Inactivated Virus, Protein Subunit, Non-replicating Viral Vector, Repurposed, RNA, DNA, Genetics
Published: 2021-06-04 (Crawled : 00:20) - prnewswire.com
NVAX | $4.15 -0.96% -0.96% 2.4M |

Health Technology

| Email alert Add to watchlist
ARCT 4 | $27.0 -3.33% -3.44% 270K |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| Email alert Add to watchlist
BNTX | News | $88.18 -0.35% -0.35% 280K |

Health Technology

| Email alert Add to watchlist
MRNA | News S | $108.82 0.86% 0.85% 3.4M |

Health Technology

| Email alert Add to watchlist
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| Email alert Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| Email alert Add to watchlist
covid genetic vaccine repurposed

---

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M |

Consumer Services

BOF | $1.99 70.09% 41.21% 110M |

ILAG | $0.51 6.03% 40.62% 1.7M |

LICN | $0.941 68.04% 40.49% 15M |

AMST | $3.31 65.5% 39.58% 70M |

Technology Services

MTC | $3.615 61.38% 38.04% 9.3M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.45 12.5% 30.92% 320K |

Health Services

MULN | News | $3.78 38.46% 27.78% 13M |

Information

RILY | $29.86 37.48% 27.26% 12M |

Finance

---

Your saved searches

---